Table 3 Procedure related and 30 days postprocedural follow-up adverse events
Variables | All patients (n = 222) | Conventional approach (n = 168) | Minimalist approach (n = 54) | P value |
|---|---|---|---|---|
Thromboembolism events, n (%) | 3 (1.35%) | 3 (1.78%) | 0 (0) | > 0.999 |
Stroke, n (%) | 3 (1.35%) | 3 (1.78%) | 0 (0) | > 0.999 |
TIA, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |
Other, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |
Pericardial effusion, n (%) | 2 (0.90%) | 1 (0.60%) | 1 (1.85%) | 0.428 |
Pericardial tamponade, n (%) | 2 (0.90%) | 1 (0.60%) | 1 (1.85%) | 0.428 |
Device embolization, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |
Device-related death, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |
Major bleedings, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |
Access-related complications, n (%) | 6 (2.70%) | 4 (2.38%) | 2 (3.70%) | 0.635 |
Groin hematoma > 6 cm, n (%) | 3 (1.35%) | 2 (1.19%) | 1 (1.85%) | 0.569 |
Femoral artery pseudoaneurysm, n (%) | 3 (1.35%) | 2 (1.19%) | 1 (1.85%) | 0.569 |
Arteriovenous fistula, n (%) | 0 (0) | 0 (0) | 0 (0) | > 0.999 |